Allencia Biosciences

Allencia Biosciences is a biotechnology company based in South San Francisco, California, focused on the discovery and development of novel small molecule therapeutics through allosteric modulation. The company leverages a proprietary platform to target allosteric sites on proteins, an approach designed to provide higher selectivity and potency for targets that are difficult to drug with traditional orthosteric inhibitors. By focusing on these unique binding sites, Allencia aims to overcome common challenges in drug resistance and off-target toxicity. Currently in the pre-clinical stage, the company is building a pipeline of programs primarily targeting high-value pathways in oncology and immunology.